10 HIV AIDS Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting HIV AIDS Studies in New Haven

NCT05910268Recruiting

Peru Decentralized HIV Care

The purpose of this study is to understand the processes by which HIV care is decentralized, an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of HIV services h...

New Haven, CTNA1,450 participantsYale University

View Study Details

NCT06694805Recruiting

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

This study will assess how effective, safe, and long-lasting a long-acting antiretroviral therapy (ART) using CAB LA + RPV LA is for people with HIV who still have detectable virus levels despite bein...

New Haven, CTPHASE3332 participantsViiV Healthcare

View Study Details

NCT06962033Recruiting

PRIDE III Prison Interventions and HIV Prevention Collaboration

The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, an...

New Haven, CTNA300 participantsYale University

View Study Details

NCT05669534Recruiting

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four interven...

New Haven, CTPHASE4256 participantsUniversity of Connecticut

View Study Details

NCT05547048Recruiting

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women invo...

New Haven, CTPHASE4250 participantsYale University

View Study Details

NCT07202546Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two differe...

New Haven, CTPHASE2150 participantsViiV Healthcare

View Study Details

NCT06784908Recruiting

Stress and Pain in People Living With HIV

This is a basic human experimental study utilizing 4 groups of individuals with and without HIV and complex morbidities of cannabis use disorder and major depression who will participate in 2 sessions...

New Haven, CTNA120 participantsYale University

View Study Details

NCT05586581Recruiting

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

The purpose of this study is to longitudinally characterize and evaluate changes in synaptic density in the brain using novel positron-emission tomography (PET) scans; magnetic resonance imaging (MRI)...

New Haven, CTPHASE170 participantsYale University

View Study Details

NCT06684613Recruiting

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

This study addresses the need for HIV prevention to be integrated into counseling visits at sexual and reproductive health clinics....

New Haven, CTNA50 participantsYale University

View Study Details

NCT07136363Recruiting

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency m...

New Haven, CTNA40 participantsUniversity of Texas Southwestern Medical Center

View Study Details

About HIV AIDS Clinical Trials in New Haven

HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.

There are currently 10 hiv aids clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 3,018 participants. Research is being sponsored by Yale University, ViiV Healthcare, University of Connecticut and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

HIV AIDS Clinical Trials in New Haven — FAQ

Are there hiv aids clinical trials in New Haven?

Yes, there are 10 hiv aids clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What hiv aids treatments are being tested?

The 10 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.

Data updated July 17, 2026 from ClinicalTrials.gov